Becton Dickinson (BDX) Tops Q3 EPS by 16c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS
August 4, 2022 6:30 AM EDTRevenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basisRevenue from continuing operations driven by base revenue growth of 6.0% as reported, 9.3% currency-neutralWorldwide COVID-only testing revenues of $76 million declined from $300 million in the prior yearGAAP diluted EPS from continuing operations of $1.28; adjusted diluted EPS from continuing operations of $2.66Company raises full year revenue and EPS guidance
FRANKLIN LAKES, N.J., Aug. 4, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its third quarter of fiscal year... More
